342 related articles for article (PubMed ID: 21278557)
1. One statin, two statins, three statins, more: similarities and differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Turkoski BB
Orthop Nurs; 2011; 30(1):62-5; quiz 66-7. PubMed ID: 21278557
[TBL] [Abstract][Full Text] [Related]
2. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
Igel M; Sudhop T; von Bergmann K
Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244
[TBL] [Abstract][Full Text] [Related]
3. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
4. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Istvan ES
Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
[TBL] [Abstract][Full Text] [Related]
5. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
Mason RP; Walter MF; Day CA; Jacob RF
Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
[TBL] [Abstract][Full Text] [Related]
6. Structural mechanism for statin inhibition of HMG-CoA reductase.
Istvan ES; Deisenhofer J
Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
[TBL] [Abstract][Full Text] [Related]
7. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase modulator: toward age- and sex-personalized medicine.
Pallottini V
Expert Opin Ther Pat; 2015; 25(10):1079-83. PubMed ID: 26135220
[TBL] [Abstract][Full Text] [Related]
8. Statin-associated adverse effects beyond muscle and liver toxicity.
Kiortsis DN; Filippatos TD; Mikhailidis DP; Elisaf MS; Liberopoulos EN
Atherosclerosis; 2007 Nov; 195(1):7-16. PubMed ID: 17094994
[TBL] [Abstract][Full Text] [Related]
9. Novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: a patent review.
Pfefferkorn JA
Expert Opin Ther Pat; 2011 Feb; 21(2):187-203. PubMed ID: 21214503
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
11. Association of statins and diabetes mellitus.
Hagedorn J; Arora R
Am J Ther; 2010; 17(2):e52-5. PubMed ID: 20019585
[TBL] [Abstract][Full Text] [Related]
12. Statin therapy: not just used to lower cholesterol?
Kronmann L; Hatfield C; Kronmann K
Crit Care Nurs Q; 2007; 30(2):154-60. PubMed ID: 17356356
[TBL] [Abstract][Full Text] [Related]
13. Statin use and breast cancer: do we need more evidence and what should this be?
Bonovas S; Lytras T; Sitaras NM
Expert Opin Drug Saf; 2014 Mar; 13(3):271-5. PubMed ID: 24517162
[TBL] [Abstract][Full Text] [Related]
14. Statins: 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors demonstrate anti-atherosclerotic character due to their antioxidant capacity.
Puttananjaiah MK; Dhale MA; Gaonkar V; Keni S
Appl Biochem Biotechnol; 2011 Jan; 163(2):215-22. PubMed ID: 20640529
[TBL] [Abstract][Full Text] [Related]
15. Statins can induce myasthenia gravis.
Gale J; Danesh-Meyer HV
J Clin Neurosci; 2014 Feb; 21(2):195-7. PubMed ID: 24433954
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic vascular protective effects of statins in perioperative medicine.
Fang SY; Roan JN; Luo CY; Tsai YC; Lam CF
Acta Anaesthesiol Taiwan; 2013 Sep; 51(3):120-6. PubMed ID: 24148741
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of statins, beyond lipid-lowering properties.
Mihos CG; Pineda AM; Santana O
Pharmacol Res; 2014 Oct; 88():12-9. PubMed ID: 24631782
[TBL] [Abstract][Full Text] [Related]
18. Statins: the next anti-endotoxin.
Kruger PS
Crit Care Resusc; 2006 Sep; 8(3):223-6. PubMed ID: 16930109
[TBL] [Abstract][Full Text] [Related]
19. The role of statins in cancer therapy.
Hindler K; Cleeland CS; Rivera E; Collard CD
Oncologist; 2006 Mar; 11(3):306-15. PubMed ID: 16549815
[TBL] [Abstract][Full Text] [Related]
20. A clinical review of statins and cancer: helpful or harmful?
Gonyeau MJ; Yuen DW
Pharmacotherapy; 2010 Feb; 30(2):177-94. PubMed ID: 20099992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
